A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection
Public ClinicalTrials.gov record NCT00736190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV Study to Evaluate the Efficacy, Safety and Tolerability of Tenofovir DF in Asian-American Adults With Chronic Hepatitis B Infection
Study identification
- NCT ID
- NCT00736190
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- Tenofovir disoproxil fumarate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2008
- Primary completion
- Jun 30, 2010
- Completion
- Jun 30, 2010
- Last update posted
- Dec 4, 2011
2008 – 2010
United States locations
- U.S. sites
- 21
- U.S. states
- 8
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Hacienda Heights | California | 91745 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Monterey Park | California | 91754 | — |
| Not listed | Mountain View | California | 94040 | — |
| Not listed | Oakland | California | 94609 | — |
| Not listed | Palo Alto | California | 94304 | — |
| Not listed | San Jose | California | 95128 | — |
| Not listed | Hamden | Connecticut | 06518 | — |
| Not listed | Baltimore | Maryland | 21234 | — |
| Not listed | Laurel | Maryland | 20707 | — |
| Not listed | Silver Spring | Maryland | 20902 | — |
| Not listed | Englewood | New Jersey | 07631 | — |
| Not listed | Brooklyn | New York | 11219 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | New York | New York | 10013 | — |
| Not listed | New York | New York | 10038 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Fairfax | Virginia | 22030 | — |
| Not listed | Falls Church | Virginia | 22044 | — |
| Not listed | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00736190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00736190 live on ClinicalTrials.gov.